Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

VEGFR

Items 11-20 of 54

Page
per page
  1. DMH4
    B5611 DMH4
     1 Citation
    Summary: VEGFR-2 inhibitor
      <20.02 mg/mL
  2. (Z)-FeCP-oxindole
    B5491 (Z)-FeCP-oxindole
    Summary: VEGFR-2 inhibitor
      insoluble in DMSO
  3. (E)-FeCP-oxindole
    B5490 (E)-FeCP-oxindole
    Summary: VEGFR-2 inhibitor
      insoluble in DMSO
  4. EG00229
    B4657 EG00229
    Summary: Nrp1 inhibitor
      ≥26.25 mg/mL
  5. Apatinib
    B2303 Apatinib
     4 Citation
    Summary: VEGFR2 inhibitor, orally bioavailable, selective
      ≥49.4 mg/mL
  6. SAR131675
    B2301 SAR131675
    Summary: VEGFR3 inhibitor,selective and ATP-competitve
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  7. CP-673451
    B2173 CP-673451
    Target: PDGFR
    Summary: PDGFRα/β inhibitor,potent and selective
  8. Tyrphostin 9
    B1494 Tyrphostin 9
    Summary: Selective EGFR/PDGFR inhibitor
      insoluble in H2O; ≥14.1 mg/mL
  9. SKLB1002
    B1305 SKLB1002
    Summary: VEGFR2 inhibitor,potent and ATP-competitve
  10. Vandetanib (ZD6474)
    A8555 Vandetanib (ZD6474)
    Target: VEGFR|EGFR
    Summary: VEGFR2/EGFR antagonist
      insoluble in H2O; ≥11.88 mg/mL

Items 11-20 of 54

Page
per page